Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock: Implications of Metabolic Bioactivation.
Saved in:
| Title: | Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock: Implications of Metabolic Bioactivation. |
|---|---|
| Authors: | Weeks PA; Department of Pharmacy, Memorial Hermann-Texas Medical Center, Houston, TX, USA phillip.weeks@memorialhermann.org., Sieg A; Department of Pharmacy, Memorial Hermann-Texas Medical Center, Houston, TX, USA., Paruthi C; Center for Advanced Heart Failure, University of Texas Health Science Center, Houston, TX, USA., Rajapreyar I; Center for Advanced Heart Failure, University of Texas Health Science Center, Houston, TX, USA. |
| Source: | Journal of cardiovascular pharmacology and therapeutics [J Cardiovasc Pharmacol Ther] 2015 Jul; Vol. 20 (4), pp. 370-7. Date of Electronic Publication: 2015 Feb 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 9602617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-4034 (Electronic) Linking ISSN: 10742484 NLM ISO Abbreviation: J Cardiovasc Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1940-4034 |
|---|---|
| DOI: | 10.1177/1074248415571456 |
